What's in Virtua Health, Inc.'s pipeline?

Virtua Health, Inc. has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Virtua Health, Inc.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/virtua-health-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Virtua Health, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtua Health, Inc. pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
5cc Vivigen and local autograft	5cc Vivigen and local autograft	marketed
Small kit rhBMP-2 with local autograft	Small kit rhBMP-2 with local autograft	marketed	Bone morphogenetic protein (growth factor)	BMP receptor type I and II (ALK3/ALK6)	Orthopedic Surgery / Bone Regeneration
Arista	Arista	marketed			Other

Therapeutic area mix

Orthopedic Surgery / Bone Regeneration · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Virtua Health, Inc.:

Cite this brief

Drug Landscape (2026). Virtua Health, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/virtua-health-inc. Accessed 2026-05-16.